CN102178952B - 一种层析法提取破伤风人免疫球蛋白的方法 - Google Patents
一种层析法提取破伤风人免疫球蛋白的方法 Download PDFInfo
- Publication number
- CN102178952B CN102178952B CN201110030795.7A CN201110030795A CN102178952B CN 102178952 B CN102178952 B CN 102178952B CN 201110030795 A CN201110030795 A CN 201110030795A CN 102178952 B CN102178952 B CN 102178952B
- Authority
- CN
- China
- Prior art keywords
- tig
- add
- chromatography
- protein
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000004587 chromatography analysis Methods 0.000 title claims abstract description 19
- 229940085526 tetanus immune globulin Drugs 0.000 title abstract description 5
- 241000700605 Viruses Species 0.000 claims abstract description 28
- 230000002779 inactivation Effects 0.000 claims abstract description 24
- 230000008569 process Effects 0.000 claims abstract description 18
- 238000001914 filtration Methods 0.000 claims abstract description 9
- 239000002120 nanofilm Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- 102000004169 proteins and genes Human genes 0.000 claims description 49
- 108090000623 proteins and genes Proteins 0.000 claims description 49
- 239000000376 reactant Substances 0.000 claims description 39
- 239000007788 liquid Substances 0.000 claims description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 30
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 25
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 25
- 238000001816 cooling Methods 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000008215 water for injection Substances 0.000 claims description 25
- 238000001556 precipitation Methods 0.000 claims description 24
- 238000000502 dialysis Methods 0.000 claims description 18
- 230000001105 regulatory effect Effects 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 15
- 206010043376 Tetanus Diseases 0.000 claims description 12
- 108060003951 Immunoglobulin Proteins 0.000 claims description 11
- 102000018358 immunoglobulin Human genes 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000008351 acetate buffer Substances 0.000 claims description 10
- 239000012501 chromatography medium Substances 0.000 claims description 10
- 239000008363 phosphate buffer Substances 0.000 claims description 10
- 238000004094 preconcentration Methods 0.000 claims description 10
- 239000006166 lysate Substances 0.000 claims description 9
- 210000002381 plasma Anatomy 0.000 claims description 9
- 238000004255 ion exchange chromatography Methods 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 238000005352 clarification Methods 0.000 claims description 5
- 239000012043 crude product Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000011100 viral filtration Methods 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims 2
- 239000011543 agarose gel Substances 0.000 claims 1
- 238000005571 anion exchange chromatography Methods 0.000 claims 1
- -1 diethyl amino ethyl group Chemical group 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 7
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract description 3
- 230000002052 anaphylactic effect Effects 0.000 abstract description 3
- 208000003455 anaphylaxis Diseases 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000010836 blood and blood product Substances 0.000 abstract description 2
- 229940125691 blood product Drugs 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 2
- 101000740484 Homo sapiens Aryl hydrocarbon receptor nuclear translocator-like protein 1 Proteins 0.000 abstract 1
- 230000002391 anti-complement effect Effects 0.000 abstract 1
- 108010008730 anticomplement Proteins 0.000 abstract 1
- 102000048700 human ARNTL Human genes 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
- 238000011097 chromatography purification Methods 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003171 anti-complementary effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术指标 | 纯度(%) | PKA(IU/ml) | 抗补体活性% | IgG单体和二聚体 | 回收率IU |
中国药典 | ≥90 | 无要求 | 无要求 | ≥90 | |
实施例一 | 99.0 | 未检出 | 7 | 99.5 | 456万 |
实施例二 | 99.2 | 3 | 5 | 99.2 | 480万 |
实施例三 | 99.2 | 3 | 5 | 99.6 | 450万 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110030795.7A CN102178952B (zh) | 2011-01-28 | 2011-01-28 | 一种层析法提取破伤风人免疫球蛋白的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110030795.7A CN102178952B (zh) | 2011-01-28 | 2011-01-28 | 一种层析法提取破伤风人免疫球蛋白的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102178952A CN102178952A (zh) | 2011-09-14 |
CN102178952B true CN102178952B (zh) | 2014-03-26 |
Family
ID=44565358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110030795.7A Active CN102178952B (zh) | 2011-01-28 | 2011-01-28 | 一种层析法提取破伤风人免疫球蛋白的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102178952B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108467430A (zh) * | 2018-05-24 | 2018-08-31 | 兰州生物制品研究所有限责任公司 | 一种免疫球蛋白制剂的纯化方法 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603891B (zh) * | 2012-03-26 | 2014-01-29 | 新疆德源生物工程有限公司 | 一种双重病毒灭活制备破伤风人免疫球蛋白的方法 |
CN103980345A (zh) * | 2014-05-07 | 2014-08-13 | 贵州中泰生物科技有限公司 | 一种低多聚体的人免疫球蛋白快速生产工艺 |
CN104004091B (zh) * | 2014-06-12 | 2016-08-17 | 新疆德源生物工程有限公司 | 一种人免疫球蛋白的制备工艺 |
CN105601736B (zh) * | 2016-01-28 | 2019-04-23 | 哈尔滨派斯菲科生物制药股份有限公司 | 一种抗呼吸道合胞病毒人免疫球蛋白及其制备方法 |
CN105669860B (zh) * | 2016-01-28 | 2019-11-22 | 哈尔滨派斯菲科生物制药股份有限公司 | 一种抗手足口病人免疫球蛋白及其制备方法 |
CN111110876A (zh) * | 2020-01-20 | 2020-05-08 | 华兰生物工程重庆有限公司 | 一种特异性人免疫球蛋白病毒灭活工艺 |
CN111991571B (zh) * | 2020-08-12 | 2022-04-05 | 湖州师范学院 | 一种柱上低pH病毒灭活的方法 |
CN114736294A (zh) * | 2022-04-24 | 2022-07-12 | 华兰生物工程重庆有限公司 | 一种破伤风免疫球蛋白的纯化方法及其亲和层析填料 |
CN115448981A (zh) * | 2022-10-20 | 2022-12-09 | 北京智飞绿竹生物制药有限公司 | 一种吸附破伤风疫苗的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101591393A (zh) * | 2009-06-30 | 2009-12-02 | 同路生物制药有限公司 | 一种狂犬病、破伤风双效价人免疫球蛋白及其制备方法以及其在制药物中的应用 |
CN101747434A (zh) * | 2010-01-19 | 2010-06-23 | 山东泰邦生物制品有限公司 | 水痘-带状疱疹人免疫球蛋白及其原料生产方法 |
-
2011
- 2011-01-28 CN CN201110030795.7A patent/CN102178952B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101591393A (zh) * | 2009-06-30 | 2009-12-02 | 同路生物制药有限公司 | 一种狂犬病、破伤风双效价人免疫球蛋白及其制备方法以及其在制药物中的应用 |
CN101747434A (zh) * | 2010-01-19 | 2010-06-23 | 山东泰邦生物制品有限公司 | 水痘-带状疱疹人免疫球蛋白及其原料生产方法 |
Non-Patent Citations (2)
Title |
---|
人破伤风免疫球蛋白的研制;赵淑良等;《中国生物制品学杂志》;19881231;38-41 * |
赵淑良等.人破伤风免疫球蛋白的研制.《中国生物制品学杂志》.1988,38-41. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108467430A (zh) * | 2018-05-24 | 2018-08-31 | 兰州生物制品研究所有限责任公司 | 一种免疫球蛋白制剂的纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102178952A (zh) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178952B (zh) | 一种层析法提取破伤风人免疫球蛋白的方法 | |
US10428107B2 (en) | Method for isolating and purifying recombinant human serum albumin from transgenic rice grain | |
CN102584934B (zh) | 一种静注人免疫球蛋白的制备工艺 | |
CN102178951B (zh) | 一种生产静注人免疫球蛋白的方法 | |
KR20180004726A (ko) | 크로마토그래피 칼럼으로부터의 생성물의 연속 용리 방법 | |
CN102161702B (zh) | 人血白蛋白的生产方法 | |
CN103554253A (zh) | 一种静注人免疫球蛋白的制备方法 | |
CN110241012B (zh) | 一种生物大分子上游分阶段截留的生产方法、生产模块及在生产中的应用 | |
JP2022526965A (ja) | キャプチャー前の凝集の使用による免疫グロブリンのアフィニティークロマトグラフィーの改善 | |
CN102532307A (zh) | 一种制备人免疫球蛋白的方法 | |
CN114181970B (zh) | 一种慢病毒载体纯化方法 | |
CN114181300A (zh) | 一种高纯度单克隆抗体的制备方法 | |
CN109575129A (zh) | 一种静注人免疫球蛋白的制备工艺 | |
CN105601735B (zh) | 一种静注巨细胞人免疫球蛋白及其制备方法 | |
CN109336967A (zh) | 基于混合填料的抗体纯化方法 | |
CN116731162B (zh) | 人免疫球蛋白生产工艺 | |
CN105669860B (zh) | 一种抗手足口病人免疫球蛋白及其制备方法 | |
US20130172536A1 (en) | Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof | |
CN109320611B (zh) | 一种人鼠嵌合单克隆抗体生物类似药的纯化方法 | |
JP2023145471A (ja) | 容積測定ローディング流量を低減し、そして結合及び溶出クロマトグラフィー精製の生産性を増大するためのインライン生成物濃縮 | |
CN105579572B (zh) | 用于净化高密度粗细胞培养收获物的方法 | |
CN112500477B (zh) | 一种快速从血浆提取人免疫球蛋白的方法 | |
CN114230669A (zh) | 一种双特异性抗体的生产方法 | |
CN101357228A (zh) | 静脉注射用人乙型肝炎免疫球蛋白的制备方法 | |
JP2012505863A (ja) | 高密度細胞における清澄化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Fengzhu Inventor after: Sun Xiaodong Inventor after: Yang Li Inventor after: Li Changlu Inventor after: Yang Jinping Inventor after: Yu Yang Inventor after: Guo Jing Inventor before: Chen Fengzhu Inventor before: Sun Xiaodong Inventor before: Wei Shu Inventor before: Li Changlu Inventor before: Yang Jinping Inventor before: Yu Yang Inventor before: Guo Jing |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN FENGZHU SUN XIAODONG WEI SHU LI CHANGLU YANG JINPING YU YANG GUO JING TO: CHEN FENGZHU SUN XIAODONG YANG LI LI CHANGLU YANG JINPING YU YANG GUO JING |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for extracting human TIG (Tetanus Immune Globulin) based on chromatography Effective date of registration: 20180627 Granted publication date: 20140326 Pledgee: Shanghai Pudong Development Bank Limited by Share Ltd Harbin branch Pledgor: Harbin Paisi Feike Biological Pharmaceutical Co., Ltd. Registration number: 2018230000007 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.77 Siping Road, Limin Economic Development Zone, Hulan District, Harbin City, Heilongjiang Province Patentee after: Harbin pesfico biopharmaceutical Co.,Ltd. Address before: 150078 No. 640 Airport Road, Daoli District, Heilongjiang, Harbin Patentee before: HARBIN PAISI FEIKE BIOLOGICAL PHARMACEUTICAL Co.,Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220609 Granted publication date: 20140326 Pledgee: Shanghai Pudong Development Bank Limited by Share Ltd. Harbin branch Pledgor: HARBIN PAISI FEIKE BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Registration number: 2018230000007 |